Rigel Pharmaceuticals closes $70M VEPPANU license deal with ARVINAS and PFIZER

Go back to Rigel Pharmaceuticals closes $70M VEPPANU license deal with ARVINAS and PFIZER
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) Delayed: 36.82 -0.98 (2.59%)
Previous Close $37.80    52 Week High $4.38 
Open $37.04    52 Week Low $1.88 
Day High $38.00    P/E N/A 
Day Low $36.54    EPS $-1.12 
Volume 383,189